INDENTURE Dated as of October 18, 2017 among CATALENT PHARMA SOLUTIONS, INC. the Guarantors listed herein and DEUTSCHE BANK TRUST COMPANY AMERICAS as Trustee 4.875% SENIOR NOTES DUE 2026Indenture • October 18th, 2017 • Catalent, Inc. • Pharmaceutical preparations • New York
This INDENTURE, dated as of October 18, 2017, is among Catalent Pharma Solutions, Inc. (the “Issuer”), a Delaware corporation, the Guarantors (as defined herein) listed on the signature pages hereto, and Deutsche Bank Trust Company Americas, a New York banking corporation, as trustee (the “Trustee”).
AMENDMENT NO. 3 TO AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • October 18th, 2017 • Catalent, Inc. • Pharmaceutical preparations • New York
AMENDMENT NO. 3 TO AMENDED AND RESTATED CREDIT AGREEMENT, dated as of October 18, 2017 (this “Amendment”), by and among CATALENT PHARMA SOLUTIONS, INC., a Delaware corporation (the “Borrower”), PTS INTERMEDIATE HOLDINGS LLC, a Delaware limited liability company (“Holdings”), MORGAN STANLEY SENIOR FUNDING, INC. (“MSSF”), as Administrative Agent (in such capacity, the “Administrative Agent”), Collateral Agent and Swing Line Lender and the Lenders party hereto.
